NYKODE THERAPEUTICS ASA financial statements, including revenue, expenses, profit, and loss
The total revenue of NYKD for the last quarter is 5.74 M NOK, and it's 1.95% lower compared to the previous quarter. The net income of Q3 24 is -104.18 M NOK.